Breaking

BioNTech to produce vaccines in Singapore, its new regional headquarters - CNBC
May 10, 2021 35 secs

SINGAPORE — BioNTech announced Monday it will set up its Southeast Asia headquarters in Singapore, and will build a manufacturing facility in the city-state to produce its messenger RNA vaccines and other medicines to treat infectious diseases and cancer.

It would allow the firm to scale up production for Southeast Asia to address future pandemic threats.

"With this planned mRNA production facility, we will increase our overall network capacity and expand our ability to manufacture and deliver our mRNA vaccines and therapies to people around the world.".

Two shots are required, 21 days apart, and the vaccine is 95% effective at preventing laboratory-confirmed Covid-19 illness in people without evidence of previous infection, the Centers for Disease Control and Prevention said.

RECENT NEWS

SUBSCRIBE

Get monthly updates and free resources.

CONNECT WITH US

© Copyright 2024 365NEWSX - All RIGHTS RESERVED